PL367310A1 - Analogi nocyceptyny - Google Patents

Analogi nocyceptyny

Info

Publication number: PL367310A1
Authority: PL; Poland
Prior art keywords: nociceptin; analogs; nociceptin analogs; orl1; modulators
Prior art date: 2001-04-18

Application number

PL02367310A

Other languages

English (en)

Inventor

Qun Sun

R.Richard Goehring

Donald Kyle

Zhengming Chen

John Whitehead

Sam Victory

Original Assignee

Euro-Celtique, S.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-18

Filing date

2002-04-18

Publication date

2005-02-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27501377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL367310(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-04-18 Application filed by Euro-Celtique, S.A. filed Critical Euro-Celtique, S.A.

2005-02-21 Publication of PL367310A1 publication Critical patent/PL367310A1/pl

Links

PULGYDLMFSFVBL-SMFNREODSA-N nociceptin Chemical class C([C@@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)[C@@H](C)O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 PULGYDLMFSFVBL-SMFNREODSA-N 0.000 title 1
101001122499 Homo sapiens Nociceptin receptor Proteins 0.000 abstract 1
102100028646 Nociceptin receptor Human genes 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Diabetes (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Anesthesiology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychology (AREA)
Physical Education & Sports Medicine (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Finishing Walls (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL02367310A 2001-04-18 2002-04-18 Analogi nocyceptyny PL367310A1 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US28466701P	2001-04-18	2001-04-18
US28466901P	2001-04-18	2001-04-18
US28466801P	2001-04-18	2001-04-18
US28466601P	2001-04-18	2001-04-18

Publications (1)

Publication Number	Publication Date
PL367310A1 true PL367310A1 (pl)	2005-02-21

Family

ID=27501377

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02367310A PL367310A1 (pl)	2001-04-18	2002-04-18	Analogi nocyceptyny

Country Status (25)

Country	Link
US (4)	US6867222B2 (pl)
EP (7)	EP1379246B1 (pl)
JP (4)	JP4364513B2 (pl)
KR (2)	KR100878774B1 (pl)
CN (1)	CN100352816C (pl)
AT (4)	ATE434607T1 (pl)
AU (1)	AU2002307416B2 (pl)
BR (1)	BR0209129A (pl)
CA (1)	CA2444198C (pl)
CL (2)	CL2009001278A1 (pl)
CY (4)	CY1108707T1 (pl)
CZ (1)	CZ20032850A3 (pl)
DE (4)	DE60232752D1 (pl)
DK (4)	DK1598338T5 (pl)
ES (4)	ES2322158T3 (pl)
HU (1)	HUP0401109A3 (pl)
IL (4)	IL158484A0 (pl)
MX (1)	MXPA03009600A (pl)
NO (1)	NO20034661L (pl)
NZ (5)	NZ540234A (pl)
PL (1)	PL367310A1 (pl)
PT (4)	PT1598340E (pl)
SI (4)	SI1598340T1 (pl)
WO (1)	WO2002085357A1 (pl)
YU (1)	YU82303A (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6615189B1 (en) *	1998-06-22	2003-09-02	Bank One, Delaware, National Association	Debit purchasing of stored value card for use by and/or delivery to others
IL158484A0 (en) *	2001-04-18	2004-05-12	Euro Celtique Sa	Nociceptin analogs
DE10252665A1 (de) *	2002-11-11	2004-06-03	Grünenthal GmbH	4-Aminomethyl-1-aryl-cyclohexylamin-Derivate
WO2004064835A1 (en) *	2003-01-17	2004-08-05	Neurosearch A/S	Use of ion channel modulating agents for treating pain
MXPA05009104A (es)	2003-02-28	2006-05-31	Bayer Pharmaceuticals Corp	Derivados de urea biciclica novedosa utiles en el tratamiento del cancer y otros trastornos.
WO2005060947A2 (en) *	2003-12-19	2005-07-07	Sri International	Agonist and antagonist ligands of the nociceptin receptor
WO2005075459A1 (en) *	2004-02-03	2005-08-18	Euro-Celtique S.A.	Synthesis of cyanoimino-benzoimidazoles
WO2006080519A1 (ja) *	2005-01-31	2006-08-03	Kyowa Hakko Kogyo Co., Ltd.	ジアミン誘導体
AU2006298852A1 (en) *	2005-09-30	2007-04-12	F. Hoffmann-La Roche Ag	Indane derivatives as MCH receptor antagonists
CA2637674A1 (en) *	2006-01-19	2007-07-26	Abbott Laboratories	2-imino-benzimidazoles
EP1987009A1 (en) *	2006-01-30	2008-11-05	Euro-Celtique S.A.	Cyclourea compounds as calcium channel blockers
TW200813018A (en)	2006-06-09	2008-03-16	Astrazeneca Ab	Novel compounds
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
US20080287479A1 (en) *	2006-12-20	2008-11-20	Pfizer Inc	Inhibitors of serine palmitoyltransferase
JP5462633B2 (ja) *	2007-01-16	2014-04-02	パーデュー、ファーマ、リミテッド、パートナーシップ	複素環置換ピペリジン化合物とその使用
WO2008105497A1 (ja) *	2007-03-01	2008-09-04	Mitsubishi Tanabe Pharma Corporation	ベンゾイミダゾール化合物およびその医薬用途
JP5554709B2 (ja)	2007-08-31	2014-07-23	パーデュー、ファーマ、リミテッド、パートナーシップ	置換キノキサリンタイプピペリジン化合物とその使用
US8119661B2 (en)	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
AU2008297936A1 (en) *	2007-09-11	2009-03-19	Mondobiotech Laboratories Ag	Use of parathyroid hormone ( 1-34 ) as anti-HIV agent
US8697722B2 (en)	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
ES2393849T7 (es)	2008-07-21	2015-01-28	Purdue Pharma Lp	Compuestos de piperidina puenteada, de tipo quinoxalina sustituida, y usos de los mismos
GB0817982D0 (en) *	2008-10-01	2008-11-05	Glaxo Group Ltd	Compounds
WO2011085389A1 (en)	2010-01-11	2011-07-14	Astraea Therapeutics, Llc	Nicotinic acetylcholine receptor modulators
JP2014532660A (ja)	2011-10-28	2014-12-08	メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋＳｈａｒｐ＆ＤｏｈｍｅＣｏｒｐ．	電位作動型ナトリウムチャネルにおける選択活性を有するベンゾオキサゾリノン化合物
TW201348231A (zh) *	2012-02-29	2013-12-01	Amgen Inc	雜雙環化合物
WO2014102588A2 (en)	2012-12-27	2014-07-03	Purdue Pharma L.P.	Indole and indoline-type piperidine compounds and uses thereof
US10118927B2 (en)	2012-12-27	2018-11-06	Purdue Pharma L.P.	Substituted piperidin-4-amino-type compounds and uses thereof
WO2014102594A2 (en) *	2012-12-27	2014-07-03	Purdue Pharma L.P.	Substituted benzimidazole-type piperidine compounds and uses thereof
US9951038B2 (en)	2012-12-27	2018-04-24	Purdue Pharma L.P.	Quinazolin-4(3H)-one-type piperidine compounds and uses thereof
WO2014106238A1 (en)	2012-12-31	2014-07-03	Fang, Qun, Kevin	Heterocyclic compounds and methods of use thereof
US10112924B2 (en)	2015-12-02	2018-10-30	Astraea Therapeutics, Inc.	Piperdinyl nociceptin receptor compounds
CA3006966A1 (en)	2015-12-02	2017-06-08	Astraea Therapeutics, Llc	Piperidinyl nociceptin receptor compounds
MX2019001224A (es)	2016-07-29	2019-06-03	Janssen Pharmaceutica Nv	Metodos para tratar el cancer de prostata.

Family Cites Families (78)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US49212A (en) *		1865-08-08		Improvement in submerged force-pumps
US171360A (en) *		1875-12-21		Improvement in mortising-machines
US3161645A (en)	1962-12-18	1964-12-15	Res Lab Dr C Janssen N V	1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en)	1964-05-06	1967-05-09	Janssen Pharmaceutica Nv	Derivatives of benzimidazolinyl piperidine
US3325499A (en) *	1964-11-02	1967-06-13	Mcneilab Inc	1-(1-hydrocarbyl-4-piperdyl)-2-indolinone
US3325490A (en) *	1965-02-23	1967-06-13	Rexall Drug Chemical	Substituted 1-hydroxydibenzopyrans
DE2609645A1 (de)	1976-03-09	1977-09-15	Boehringer Sohn Ingelheim	Aminoalkylheterocyclen
EP0029707B1 (en)	1979-11-21	1984-02-01	Kyowa Hakko Kogyo Co., Ltd	Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
US4329353A (en)	1980-10-22	1982-05-11	Janssen Pharmaceutica, N.V.	1-(4-Aryl-cyclohexyl)piperidine derivatives, method of use thereof and pharmaceutical compositions thereof
US4410528A (en)	1980-05-16	1983-10-18	Kyowa Hakko Kogyo Co., Ltd.	Hypotensive piperidine derivatives
JPS58180481A (ja)	1982-04-15	1983-10-21	Kyowa Hakko Kogyo Co Ltd	新規なピペリジン誘導体
JPS60120872A (ja)	1983-12-01	1985-06-28	Kyowa Hakko Kogyo Co Ltd	新規なヘテロ環状化合物及び強心剤
DE3827641A1 (de) *	1988-08-16	1990-03-08	Basf Ag	2,6-polyalkylpiperidinsubstituierte bislactame und deren verwendung zum stabilisieren von organischem material, insbesondere von kunststoffen und damit stabilisiertes material
DE4332168A1 (de)	1993-02-22	1995-03-23	Thomae Gmbh Dr K	Cyclische Derivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
AU691829B2 (en) *	1993-07-16	1998-05-28	Merck & Co., Inc.	Benzoxazinone and benzopyrimidinone piperidinyl tocolytic oxytocin receptor antagonists
FR2708608B1 (fr) *	1993-07-30	1995-10-27	Sanofi Sa	Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
GB9325074D0 (en)	1993-12-07	1994-02-02	Zeneca Ltd	Bicyclic heterocycles
JPH09512016A (ja) *	1994-04-14	1997-12-02	メルクエンドカンパニーインコーポレーテッド	α１Ｃアドレナリン受容体拮抗薬
FR2722190B1 (fr) *	1994-07-05	1996-10-04	Sanofi Sa	Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
AU3192295A (en) *	1994-08-11	1996-03-07	Yamanouchi Pharmaceutical Co., Ltd.	Substituted amine derivative and medicinal composition containing the same
US5767118A (en) *	1994-10-26	1998-06-16	Merck & Co., Inc.	4-Heterocyclic peperidines promote release of growth hormone
US5574044A (en) *	1994-10-27	1996-11-12	Merck & Co., Inc.	Muscarine antagonists
CA2200468A1 (en) *	1994-10-27	1996-05-09	Wayne J. Thompson	Muscarine antagonists
US5576321A (en) *	1995-01-17	1996-11-19	Eli Lilly And Company	Compounds having effects on serotonin-related systems
US5789402A (en) *	1995-01-17	1998-08-04	Eli Lilly Company	Compounds having effects on serotonin-related systems
GB9603457D0 (pl) *	1996-02-19	1996-04-17	Merck & Co Inc
HRP960159A2 (en)	1995-04-21	1997-08-31	Bayer Ag	Benzocyclopentane oxazolidinones containing heteroatoms
ATE301457T1 (de)	1995-06-12	2005-08-15	Searle & Co	Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
AU6943996A (en)	1995-09-13	1997-04-01	Kyowa Hakko Kogyo Co. Ltd.	Phenylpiperidine derivatives
ZA9610745B (en) *	1995-12-22	1997-06-24	Warner Lambert Co	4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
AU722747B2 (en) *	1996-03-30	2000-08-10	Roche Diagnostics Gmbh	Novel oxazolidine derivatives, process for their production and medicaments containing them
EP0944388A4 (en) *	1996-04-03	2001-08-16	Merck & Co Inc	INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
US5891889A (en) *	1996-04-03	1999-04-06	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
US6180649B1 (en)	1996-04-19	2001-01-30	Nerosearch A/S	1-(4-piperidyl)-benzimidazoles having neurotrophic activity
BR9712023A (pt) *	1996-09-10	1999-08-31	Thomae Gmbh Dr K	Aminoácidos derivados, medicamentos contendo esses compostos e processos para a sua preparação.
US5977134A (en)	1996-12-05	1999-11-02	Merck & Co., Inc.	Inhibitors of farnesyl-protein transferase
WO1998032439A1 (en)	1997-01-23	1998-07-30	Smithkline Beecham Corporation	Il-8 receptor antagonists
US6117973A (en)	1997-02-24	2000-09-12	Georgia Tech Research Corp.	PNA monomers with electron donor or acceptor
TWI242011B (en) *	1997-03-31	2005-10-21	Eisai Co Ltd	1,4-substituted cyclic amine derivatives
US6063796A (en) *	1997-04-04	2000-05-16	Merck & Co., Inc.	Somatostatin agonists
AU732329B2 (en)	1997-05-30	2001-04-12	Banyu Pharmaceutical Co., Ltd.	2-oxoimidazole derivative
JPH10330377A (ja) *	1997-06-02	1998-12-15	Kyowa Hakko Kogyo Co Ltd	ピペリジン誘導体
US6166037A (en)	1997-08-28	2000-12-26	Merck & Co., Inc.	Pyrrolidine and piperidine modulators of chemokine receptor activity
EP1009405A4 (en) *	1997-08-28	2001-05-09	Merck & Co Inc	PAYRROLIDINE AND PIPERIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
EP0921125B1 (en)	1997-12-05	2002-01-30	F. Hoffmann-La Roche Ag	1,3,8-Triazaspiro[4,5]decan-4-on derivatives
US6166209A (en)	1997-12-11	2000-12-26	Hoffmann-La Roche Inc.	Piperidine derivatives
WO1999032481A1 (en) *	1997-12-23	1999-07-01	Alcon Laboratories, Inc.	Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
WO1999036421A1 (en)	1998-01-19	1999-07-22	Pfizer Pharmaceuticals Inc.	4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
WO1999037304A1 (en)	1998-01-27	1999-07-29	Aventis Pharmaceuticals Products Inc.	SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS
TR200003598T2 (tr)	1998-03-26	2001-06-21	Japan Tobacco Inc.	Amid türevleri ve nosiseptin antagonistleri
WO1999059997A1 (en)	1998-05-18	1999-11-25	Novo Nordisk A/S	Novel 1,3,8-triazaspiro[4.5]decanones with high affinity for opioid receptor subtypes
US6262066B1 (en)	1998-07-27	2001-07-17	Schering Corporation	High affinity ligands for nociceptin receptor ORL-1
ID29137A (id) *	1998-07-27	2001-08-02	Schering Corp	Ligan-ligan afinitas tinggi untuk reseptor nosiseptin orl-1
MA26659A1 (fr)	1998-08-06	2004-12-20	Pfizer	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
US6573218B1 (en)	1998-09-09	2003-06-03	Ishihara Sangyo Kaisha, Ltd.	Fused-benzene derivatives useful as herbicides
US6204265B1 (en)	1998-12-23	2001-03-20	Schering Corporation	Substituted oximes and hydrazones as neurokinin antagonists
WO2000039114A2 (en)	1998-12-23	2000-07-06	Schering Corporation	Substituted oximes and hydrazones as neurokinin antagonists
AU1691500A (en) *	1998-12-24	2000-07-31	Meiji Seika Kaisha Ltd.	Remedies for pain
JP4011819B2 (ja) *	1999-04-12	2007-11-21	エーザイ・アール・アンド・ディー・マネジメント株式会社	インドール誘導体の製造法およびその中間体
CA2341542A1 (en)	1999-06-24	2000-12-28	Toray Industries, Inc.	.alpha.1b-adrenergic receptor antagonists
US6340681B1 (en)	1999-07-16	2002-01-22	Pfizer Inc	2-benzimidazolylamine compounds as ORL-1-receptor agonists
MXPA02000340A (es) *	1999-07-21	2002-06-21	Fujisawa Pharmaceutical Co	Derivados de benzimidazolona y su uso como inhibidores fosfodiesterasa.
US7456198B2 (en) *	1999-12-06	2008-11-25	Purdue Pharma L.P.	Benzimidazole compounds having nociceptin receptor affinity
SE9904652D0 (sv) *	1999-12-17	1999-12-17	Astra Pharma Prod	Novel Compounds
ATE306488T1 (de)	2000-01-05	2005-10-15	Pfizer	Benzimidazol-verbindungen zur verwendung als orl1-rezeptor-antagonisten
CA2400640A1 (en) *	2000-02-18	2001-08-23	Meiji Seika Kaisha, Ltd.	Phenoxyalkylamine derivatives useful as opioid .delta. receptor ligands
US6476050B2 (en) *	2000-03-14	2002-11-05	Sepracor, Inc.	3-substituted piperidines comprising urea functionality, and methods of use thereof
US6790854B2 (en) *	2000-03-24	2004-09-14	Meiji Seika Kaisha, Ltd.	Diphenylalkylamine derivatives useful as opioid receptor agonists
TWI295293B (en)	2000-05-29	2008-04-01	Chugai Pharmaceutical Co Ltd	Method for preparing nitrogen-containing compounds
EP1167969A2 (en)	2000-06-14	2002-01-02	Pfizer Inc.	Method and system for predicting pharmacokinetic properties
RU2317988C2 (ru) *	2000-08-14	2008-02-27	Орто-Макнейл Фармасьютикал, Инк.	Замещенные пиразолы, фармацевтическая композиция на их основе, применение фармацевтической композиции и способ ингибирования активности катепсина s
NZ524681A (en) *	2000-09-06	2005-09-30	Ortho Mcneil Pharm Inc	A method for treating allergies using substituted pyrazoles
US20040267010A1 (en) *	2001-02-02	2004-12-30	Forbes Ian Thomson	Sulfonamide compounds, their preparation and use
AR035230A1 (es) *	2001-03-19	2004-05-05	Astrazeneca Ab	Compuestos de bencimidazol, proceso para su preparacion, composicion farmaceutica, proceso para la preparacion de dicha composicion farmaceutica, y usos de estos compuestos para la elaboracion de medicamentos
IL158484A0 (en)	2001-04-18	2004-05-12	Euro Celtique Sa	Nociceptin analogs
DE60233043D1 (de)	2001-04-19	2009-09-03	Eisai R&D Man Co Ltd	2-iminoimidazolderivate
PL368919A1 (pl)	2001-10-22	2005-04-04	Pfizer Products Inc.	Pochodne 3-azabicyklo[3.1.0]heksanu jako antagoniści receptorów opioidowych
WO2003037890A2 (en)	2001-11-01	2003-05-08	Icagen, Inc.	Piperidines

2002
- 2002-04-18 IL IL15848402A patent/IL158484A0/xx unknown
- 2002-04-18 AU AU2002307416A patent/AU2002307416B2/en not_active Ceased
- 2002-04-18 WO PCT/US2002/012351 patent/WO2002085357A1/en not_active Ceased
- 2002-04-18 CN CNB028121694A patent/CN100352816C/zh not_active Expired - Fee Related
- 2002-04-18 EP EP02764236A patent/EP1379246B1/en not_active Expired - Lifetime
- 2002-04-18 DK DK05014115.9T patent/DK1598338T5/da active
- 2002-04-18 PT PT05014117T patent/PT1598340E/pt unknown
- 2002-04-18 ES ES05014115T patent/ES2322158T3/es not_active Expired - Lifetime
- 2002-04-18 EP EP05014116A patent/EP1598339B1/en not_active Expired - Lifetime
- 2002-04-18 NZ NZ540234A patent/NZ540234A/en not_active IP Right Cessation
- 2002-04-18 SI SI200230819T patent/SI1598340T1/sl unknown
- 2002-04-18 YU YU82303A patent/YU82303A/sh unknown
- 2002-04-18 NZ NZ540233A patent/NZ540233A/en not_active IP Right Cessation
- 2002-04-18 NZ NZ528977A patent/NZ528977A/en not_active IP Right Cessation
- 2002-04-18 AT AT05014116T patent/ATE434607T1/de not_active IP Right Cessation
- 2002-04-18 DE DE60232752T patent/DE60232752D1/de not_active Expired - Lifetime
- 2002-04-18 CZ CZ20032850A patent/CZ20032850A3/cs unknown
- 2002-04-18 EP EP05014117A patent/EP1598340B1/en not_active Expired - Lifetime
- 2002-04-18 MX MXPA03009600A patent/MXPA03009600A/es active IP Right Grant
- 2002-04-18 SI SI200230847T patent/SI1598339T1/sl unknown
- 2002-04-18 BR BR0209129-1A patent/BR0209129A/pt not_active IP Right Cessation
- 2002-04-18 EP EP08150838A patent/EP1918279A3/en not_active Withdrawn
- 2002-04-18 AT AT05014115T patent/ATE423098T1/de active
- 2002-04-18 PL PL02367310A patent/PL367310A1/pl not_active Application Discontinuation
- 2002-04-18 PT PT02764236T patent/PT1379246E/pt unknown
- 2002-04-18 ES ES05014117T patent/ES2323876T3/es not_active Expired - Lifetime
- 2002-04-18 EP EP08172606A patent/EP2050450A1/en not_active Withdrawn
- 2002-04-18 DE DE60231257T patent/DE60231257D1/de not_active Expired - Lifetime
- 2002-04-18 KR KR1020067024967A patent/KR100878774B1/ko not_active Expired - Fee Related
- 2002-04-18 SI SI200230780T patent/SI1379246T1/sl unknown
- 2002-04-18 JP JP2002582930A patent/JP4364513B2/ja not_active Expired - Fee Related
- 2002-04-18 EP EP05014115A patent/EP1598338B9/en not_active Expired - Lifetime
- 2002-04-18 KR KR1020037013822A patent/KR100847296B1/ko not_active Expired - Fee Related
- 2002-04-18 PT PT05014116T patent/PT1598339E/pt unknown
- 2002-04-18 AT AT02764236T patent/ATE410165T1/de active
- 2002-04-18 DK DK02764236T patent/DK1379246T3/da active
- 2002-04-18 HU HU0401109A patent/HUP0401109A3/hu unknown
- 2002-04-18 DE DE60231442T patent/DE60231442D1/de not_active Expired - Lifetime
- 2002-04-18 NZ NZ540235A patent/NZ540235A/en unknown
- 2002-04-18 EP EP08150837A patent/EP1930322A1/en not_active Withdrawn
- 2002-04-18 US US10/126,471 patent/US6867222B2/en not_active Expired - Lifetime
- 2002-04-18 DK DK05014116T patent/DK1598339T3/da active
- 2002-04-18 DK DK05014117T patent/DK1598340T3/da active
- 2002-04-18 AT AT05014117T patent/ATE424385T1/de active
- 2002-04-18 CA CA2444198A patent/CA2444198C/en not_active Expired - Fee Related
- 2002-04-18 ES ES05014116T patent/ES2329252T3/es not_active Expired - Lifetime
- 2002-04-18 SI SI200230811T patent/SI1598338T1/sl unknown
- 2002-04-18 PT PT05014115T patent/PT1598338E/pt unknown
- 2002-04-18 DE DE60229224T patent/DE60229224D1/de not_active Expired - Lifetime
- 2002-04-18 NZ NZ551453A patent/NZ551453A/en unknown
- 2002-04-18 ES ES02764236T patent/ES2315394T3/es not_active Expired - Lifetime
2003
- 2003-10-17 NO NO20034661A patent/NO20034661L/no not_active Application Discontinuation
- 2003-10-19 IL IL158484A patent/IL158484A/en not_active IP Right Cessation
2005
- 2005-01-11 US US11/032,955 patent/US7495109B2/en not_active Expired - Fee Related
2009
- 2009-01-08 CY CY20091100010T patent/CY1108707T1/el unknown
- 2009-02-23 US US12/390,683 patent/US7939670B2/en not_active Expired - Lifetime
- 2009-04-29 CY CY20091100475T patent/CY1109053T1/el unknown
- 2009-05-22 CY CY20091100552T patent/CY1109092T1/el unknown
- 2009-05-25 CL CL2009001278A patent/CL2009001278A1/es unknown
- 2009-05-25 CL CL2009001279A patent/CL2009001279A1/es unknown
- 2009-06-24 JP JP2009150368A patent/JP5081870B2/ja not_active Expired - Fee Related
- 2009-06-24 JP JP2009150369A patent/JP5189562B2/ja not_active Expired - Fee Related
- 2009-06-24 JP JP2009150370A patent/JP2009263380A/ja active Pending
- 2009-09-10 CY CY20091100940T patent/CY1109352T1/el unknown
2010
- 2010-10-24 IL IL208907A patent/IL208907A/en not_active IP Right Cessation
- 2010-10-24 IL IL208903A patent/IL208903A/en not_active IP Right Cessation
2011
- 2011-03-18 US US13/051,629 patent/US8252815B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1930322A1 (en)	2008-06-11
CL2009001279A1 (es)	2009-11-27
IL208903A (en)	2012-07-31
EP1598340B1 (en)	2009-03-04
CN100352816C (zh)	2007-12-05
HK1088891A1 (en)	2006-11-17
PT1598338E (pt)	2009-05-08
ATE434607T1 (de)	2009-07-15
JP2005518330A (ja)	2005-06-23
EP1379246A1 (en)	2004-01-14
EP1918279A2 (en)	2008-05-07
EP1598338B9 (en)	2009-11-18
HK1063149A1 (en)	2004-12-17
ATE424385T1 (de)	2009-03-15
US20120095049A1 (en)	2012-04-19
DK1598340T3 (da)	2009-05-11
ES2315394T3 (es)	2009-04-01
HK1088892A1 (en)	2006-11-17
US6867222B2 (en)	2005-03-15
ES2323876T3 (es)	2009-07-27
DK1598339T3 (da)	2009-09-28
EP1918279A3 (en)	2008-07-16
CL2009001278A1 (es)	2009-10-09
EP1379246B1 (en)	2008-10-08
US8252815B2 (en)	2012-08-28
JP2009263378A (ja)	2009-11-12
MXPA03009600A (es)	2004-04-02
NZ540234A (en)	2007-01-26
CN1561211A (zh)	2005-01-05
DE60231257D1 (de)	2009-04-02
US20050159452A1 (en)	2005-07-21
DE60231442D1 (de)	2009-04-16
IL208907A (en)	2012-09-24
NO20034661D0 (no)	2003-10-17
NZ540233A (en)	2007-02-23
NZ528977A (en)	2005-10-28
PT1379246E (pt)	2009-01-14
ATE423098T1 (de)	2009-03-15
JP4364513B2 (ja)	2009-11-18
PT1598339E (pt)	2009-09-03
HUP0401109A2 (hu)	2004-09-28
IL208907A0 (en)	2011-01-31
IL158484A (en)	2010-12-30
NZ551453A (en)	2008-02-29
ES2322158T3 (es)	2009-06-17
NO20034661L (no)	2003-12-17
AU2002307416B2 (en)	2005-08-11
WO2002085357A1 (en)	2002-10-31
CY1108707T1 (el)	2014-04-09
ES2329252T3 (es)	2009-11-24
JP2009263379A (ja)	2009-11-12
NZ540235A (en)	2007-01-26
DE60232752D1 (de)	2009-08-06
EP1379246A4 (en)	2005-09-28
US7495109B2 (en)	2009-02-24
KR20060127421A (ko)	2006-12-12
SI1598338T1 (sl)	2009-06-30
IL158484A0 (en)	2004-05-12
EP1598340A1 (en)	2005-11-23
US20090156640A1 (en)	2009-06-18
US20030069249A1 (en)	2003-04-10
EP1598339B1 (en)	2009-06-24
EP1598338B1 (en)	2009-02-18
SI1379246T1 (sl)	2009-04-30
KR20030096328A (ko)	2003-12-24
CY1109352T1 (el)	2012-05-23
CA2444198A1 (en)	2002-10-31
CY1109092T1 (el)	2014-07-02
YU82303A (sh)	2006-03-03
EP1598339A1 (en)	2005-11-23
CZ20032850A3 (cs)	2004-02-18
SI1598340T1 (sl)	2009-08-31
JP2009263380A (ja)	2009-11-12
DK1379246T3 (da)	2009-01-26
PT1598340E (pt)	2009-04-13
BR0209129A (pt)	2005-12-20
EP2050450A1 (en)	2009-04-22
JP5189562B2 (ja)	2013-04-24
CY1109053T1 (el)	2014-07-02
SI1598339T1 (sl)	2009-12-31
CA2444198C (en)	2010-06-22
KR100878774B1 (ko)	2009-01-14
HUP0401109A3 (en)	2007-12-28
ATE410165T1 (de)	2008-10-15
DK1598338T5 (da)	2010-01-18
HK1086000A1 (en)	2006-09-08
DK1598338T3 (da)	2009-06-08
JP5081870B2 (ja)	2012-11-28
IL208903A0 (en)	2011-01-31
US7939670B2 (en)	2011-05-10
KR100847296B1 (ko)	2008-07-23
EP1598338A1 (en)	2005-11-23
DE60229224D1 (de)	2008-11-20

Legal Events

Date	Code	Title	Description
2012-01-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL208907A0 (en)	2011-01-31	Nociceptin analogs
DE60219478D1 (en)	2007-05-24	Orale gabe von 6-hydroxy-oxymorphon als analgetikum
ZA200305126B (en)	2004-10-01	Methods of administering epothilone analogs for the treatment of cancer.
ZA200305691B (en)	2005-02-23	The use of substituted azetidione compounds for the treatment of sitosterolemia
IL202688A0 (en)	2010-06-30	Novel use of a compound for treating diabetic neuropathic pain
PL1694318T3 (pl)	2007-07-31	(S)-2-N-propyloamino-5-hydroksytetrahydronaftalen jako D3-agonistyczny środek terapeutyczny
PL1696905T3 (pl)	2008-08-29	Zastosowanie podstawionych 2-aminotetralin do zapobiegawczego leczenia choroby parkinsona
SE0101082D0 (sv)	2001-03-27	Novel use
EP1461030A4 (en)	2005-06-01	AMINOALKYL-BENZOFURAN-5-OL COMPOUNDS FOR THE TREATMENT OF GLAUCOMA
PT1492501E (pt)	2009-03-26	Métodos de uso de corpos lamelares para propósitos terapêuticos
HRP20030677A2 (en)	2004-08-31	Methods of administering epothilone analogs for the treatment of cancer
AU2002364711A8 (en)	2003-06-30	Substituted 5-hydroxy-indole compounds for the treatment of glaucoma
GB0328295D0 (en)	2004-01-07	Therapeutic compounds
ZA200400824B (en)	2004-07-20	Pyridin-2-yl-methlyamine derivatives for treating opioid dependence.
AU2002327697A1 (en)	2003-04-07	Compounds for the treatment of pain
SI1485057T1 (sl)	2006-04-30	Derivati azaspiro spojin za zdravljenje bolecine
SI1485352T1 (en)	2005-10-31	Azaspiro compounds for the treatment of pain